Cargando…

Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy

BACKGROUND: Analyzing urinary biomarkers may provide better insight into pathophysiological mechanisms of diabetic kidney diseases. The study aimed to analyze the pattern of selected excreted urinary biomarkers and its correlation with albuminuria and estimated glomerular filtration rate (eGFR) in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddiqui, Khalid, Joy, Salini Scaria, George, Teena Puthiyaparampil, Mujammami, Muhammad, Alfadda, Assim A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780984/
https://www.ncbi.nlm.nih.gov/pubmed/33408494
http://dx.doi.org/10.2147/DMSO.S282166
_version_ 1783631600227975168
author Siddiqui, Khalid
Joy, Salini Scaria
George, Teena Puthiyaparampil
Mujammami, Muhammad
Alfadda, Assim A
author_facet Siddiqui, Khalid
Joy, Salini Scaria
George, Teena Puthiyaparampil
Mujammami, Muhammad
Alfadda, Assim A
author_sort Siddiqui, Khalid
collection PubMed
description BACKGROUND: Analyzing urinary biomarkers may provide better insight into pathophysiological mechanisms of diabetic kidney diseases. The study aimed to analyze the pattern of selected excreted urinary biomarkers and its correlation with albuminuria and estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes. METHODS: A total of 185 patients with type 2 diabetes were categorized according to KDIGO guideline based on albuminuria and eGFR. The urinary markers (transferrin, KIM-1, RBP, MCP-1 and NGAL) were measured by ELISA. RESULTS: The urinary markers were associated with eGFR (total protein/Cr, p=0.001; RBP/Cr, p=0.007; MCP-1/Cr, p=0.023; NGAL/Cr, p=0.011) and albuminuria (total protein/Cr, p<0.001; transferrin, p<0.001; RBP/Cr, p<0.001; MCP-1/Cr, p<0.001; NGAL/Cr, p=0.002). CONCLUSION: The urinary marker levels (total protein, RBP, MCP-1, and NGAL) are elevated with severity of kidney damage and expressed more in progressive renal impairment.
format Online
Article
Text
id pubmed-7780984
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-77809842021-01-05 Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy Siddiqui, Khalid Joy, Salini Scaria George, Teena Puthiyaparampil Mujammami, Muhammad Alfadda, Assim A Diabetes Metab Syndr Obes Original Research BACKGROUND: Analyzing urinary biomarkers may provide better insight into pathophysiological mechanisms of diabetic kidney diseases. The study aimed to analyze the pattern of selected excreted urinary biomarkers and its correlation with albuminuria and estimated glomerular filtration rate (eGFR) in patients with type 2 diabetes. METHODS: A total of 185 patients with type 2 diabetes were categorized according to KDIGO guideline based on albuminuria and eGFR. The urinary markers (transferrin, KIM-1, RBP, MCP-1 and NGAL) were measured by ELISA. RESULTS: The urinary markers were associated with eGFR (total protein/Cr, p=0.001; RBP/Cr, p=0.007; MCP-1/Cr, p=0.023; NGAL/Cr, p=0.011) and albuminuria (total protein/Cr, p<0.001; transferrin, p<0.001; RBP/Cr, p<0.001; MCP-1/Cr, p<0.001; NGAL/Cr, p=0.002). CONCLUSION: The urinary marker levels (total protein, RBP, MCP-1, and NGAL) are elevated with severity of kidney damage and expressed more in progressive renal impairment. Dove 2020-12-31 /pmc/articles/PMC7780984/ /pubmed/33408494 http://dx.doi.org/10.2147/DMSO.S282166 Text en © 2020 Siddiqui et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Siddiqui, Khalid
Joy, Salini Scaria
George, Teena Puthiyaparampil
Mujammami, Muhammad
Alfadda, Assim A
Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
title Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
title_full Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
title_fullStr Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
title_full_unstemmed Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
title_short Potential Role and Excretion Level of Urinary Transferrin, KIM-1, RBP, MCP-1 and NGAL Markers in Diabetic Nephropathy
title_sort potential role and excretion level of urinary transferrin, kim-1, rbp, mcp-1 and ngal markers in diabetic nephropathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780984/
https://www.ncbi.nlm.nih.gov/pubmed/33408494
http://dx.doi.org/10.2147/DMSO.S282166
work_keys_str_mv AT siddiquikhalid potentialroleandexcretionlevelofurinarytransferrinkim1rbpmcp1andngalmarkersindiabeticnephropathy
AT joysaliniscaria potentialroleandexcretionlevelofurinarytransferrinkim1rbpmcp1andngalmarkersindiabeticnephropathy
AT georgeteenaputhiyaparampil potentialroleandexcretionlevelofurinarytransferrinkim1rbpmcp1andngalmarkersindiabeticnephropathy
AT mujammamimuhammad potentialroleandexcretionlevelofurinarytransferrinkim1rbpmcp1andngalmarkersindiabeticnephropathy
AT alfaddaassima potentialroleandexcretionlevelofurinarytransferrinkim1rbpmcp1andngalmarkersindiabeticnephropathy